On the molecular level, breast cancer is a heterogeneous disease, which could be categorized into subtypes mainly based on the presence or absence of molecular markers for human epidermal growth factor receptor 2 (HER2) and hormone receptors [HR, including estrogen receptor (ER) and progesterone receptor] and/or BRCA mutations (2). This evidence concerns the gene ESR1 and breast carcinoma.